Conmed earnings were $54.8M for the trailing 12 months ending Mar 31, 2026, with -53.9% growth year over year. The latest CNMD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $13.8M, down 17.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CNMD reported annual earnings of $47.1M, with -64.5% growth.
CNMD past earnings growth
How has CNMD's earnings growth performed historically?
Conmed (NYSE: CNMD) reported Q1 2026 earnings per share (EPS) of $0.45, up 136.84% year over year. Total CNMD earnings for the quarter were $13.83 million. In the same quarter last year, Conmed's earnings per share (EPS) was $0.19.
As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $54.85 million, a 53.81% decrease year over year.
What was CNMD's earnings growth in the past year?
As of Conmed's earnings date in Q2 2026, Conmed's earnings has grown -53.91% year over year. This is 82.78 percentage points lower than the US Medical Devices industry earnings growth rate of 28.87%. CNMD earnings in the past year totalled $54.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.